http://www.healthblognews.com Sun, 14 Mar 2010 10:49:32 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 http://www.healthblognews.com/women-with-gout-at-greater-risk-of-heart-attack-than-men-2/ http://www.healthblognews.com/women-with-gout-at-greater-risk-of-heart-attack-than-men-2/#comments Sun, 14 Mar 2010 10:48:19 +0000 Healthblognews.com http://www.healthblognews.com/women-with-gout-at-greater-risk-of-heart-attack-than-men-2/ Women with gout are at greater risk of a heart attack than men with the disease, indicates research published ahead of print in the Annals of the Rheumatic Diseases. Gout is known to boost the risk of a heart attack in men. But to date, little has been known about the impact of gout on women’s cardiovascular health…

]]> http://www.healthblognews.com/women-with-gout-at-greater-risk-of-heart-attack-than-men-2/feed/ 0 http://www.healthblognews.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout/ http://www.healthblognews.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout/#comments Sun, 14 Mar 2010 10:48:19 +0000 Healthblognews.com http://www.healthblognews.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout/ Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group and Menarini, the first Italian pharmaceutical Group in the world with a significant pan-European presence, announced the launch of ADENURIC® (febuxostat) in France where they will co-promote the drug. Other launches by Menarini are planned shortly, notably in United Kingdom, Germany and Ireland…

]]> http://www.healthblognews.com/launch-by-menarini-and-ipsen-of-adenuricr-febuxostat-in-france-for-the-treatment-of-chronic-hyperuricemia-in-gout/feed/ 0 http://www.healthblognews.com/what-is-bursitis-what-causes-bursitis-2/ http://www.healthblognews.com/what-is-bursitis-what-causes-bursitis-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/what-is-bursitis-what-causes-bursitis-2/ Bursitis happens when the bursa is inflamed. The burse acts as a cushion between bones, tendons, joints and muscles – bursae are fluid-filled sacs (the plural of bursa is bursae). People with bursitis will feel pain at the site of inflammation. The medical word “bursa” comes from the Latin bursa, meaning a purse, which is what a bursa resembles…

]]> http://www.healthblognews.com/what-is-bursitis-what-causes-bursitis-2/feed/ 0 http://www.healthblognews.com/new-diagnostic-method-for-gout-dual-energy-computed-tomography-instead-of-joint-aspiration-3/ http://www.healthblognews.com/new-diagnostic-method-for-gout-dual-energy-computed-tomography-instead-of-joint-aspiration-3/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/new-diagnostic-method-for-gout-dual-energy-computed-tomography-instead-of-joint-aspiration-3/ The most reliable method of diagnosing gout is to aspirate the joint in order to obtain fluid to verify the presence of monosodiumurate crystals (uric acid). Up to now, computed tomography (CT) has played a limited role in the evaluation of gout, since conventional CT systems cannot reliably verify deposits of uric acid…

]]> http://www.healthblognews.com/new-diagnostic-method-for-gout-dual-energy-computed-tomography-instead-of-joint-aspiration-3/feed/ 0 http://www.healthblognews.com/role-for-innate-not-adaptive-immunity-revealed-by-autoinflammatory-disease-model-2/ http://www.healthblognews.com/role-for-innate-not-adaptive-immunity-revealed-by-autoinflammatory-disease-model-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/role-for-innate-not-adaptive-immunity-revealed-by-autoinflammatory-disease-model-2/ Researchers at the University of California, San Diego School of Medicine have developed the first mouse model for auto-inflammatory diseases, disorders that involve the over-activation of the body’s innate, primitive immune system. Their study, published early on-line in Cell Immunity on June 4, suggests that the innate – not adaptive – immune system drives auto-inflammatory diseases…

]]> http://www.healthblognews.com/role-for-innate-not-adaptive-immunity-revealed-by-autoinflammatory-disease-model-2/feed/ 0 http://www.healthblognews.com/ardea-biosciences-announces-positive-interim-phase-2a-results-for-lead-gout-drug-rdea594-2/ http://www.healthblognews.com/ardea-biosciences-announces-positive-interim-phase-2a-results-for-lead-gout-drug-rdea594-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/ardea-biosciences-announces-positive-interim-phase-2a-results-for-lead-gout-drug-rdea594-2/ Ardea Biosciences, Inc. (Nasdaq:RDEA) announced positive interim results from an ongoing Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, as well as additional positive results from completed Phase 1 studies of RDEA594 in normal, healthy volunteers…

]]> http://www.healthblognews.com/ardea-biosciences-announces-positive-interim-phase-2a-results-for-lead-gout-drug-rdea594-2/feed/ 0 http://www.healthblognews.com/fda-appointed-arthritis-advisory-committee-recommends-u-s-food-and-drug-administration-approval-for-krystexxatm-for-refractory-chronic-gout-2/ http://www.healthblognews.com/fda-appointed-arthritis-advisory-committee-recommends-u-s-food-and-drug-administration-approval-for-krystexxatm-for-refractory-chronic-gout-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/fda-appointed-arthritis-advisory-committee-recommends-u-s-food-and-drug-administration-approval-for-krystexxatm-for-refractory-chronic-gout-2/ Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated uricase enzyme, be granted marketing approval by the FDA for the treatment of refractory chronic gout…

]]> http://www.healthblognews.com/fda-appointed-arthritis-advisory-committee-recommends-u-s-food-and-drug-administration-approval-for-krystexxatm-for-refractory-chronic-gout-2/feed/ 0 http://www.healthblognews.com/johns-hopkins-scientists-out-a-gene-for-gout-2/ http://www.healthblognews.com/johns-hopkins-scientists-out-a-gene-for-gout-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/johns-hopkins-scientists-out-a-gene-for-gout-2/ Having partnered last year with an international team that surveyed the genomes of 12,000 individuals to find a genetic cause for gout, Johns Hopkins scientists now have shown that the malfunctioning gene they helped uncover can lead to high concentrations of blood urate that forms crystals in joint tissue, causing inflammation and pain – the hallmark of this disease…

]]> http://www.healthblognews.com/johns-hopkins-scientists-out-a-gene-for-gout-2/feed/ 0 http://www.healthblognews.com/scientists-out-a-gene-for-gout-2/ http://www.healthblognews.com/scientists-out-a-gene-for-gout-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/scientists-out-a-gene-for-gout-2/ Having partnered last year with an international team that surveyed the genomes of 12,000 individuals to find a genetic cause for gout, Johns Hopkins scientists now have shown that the malfunctioning gene they helped uncover can lead to high concentrations of blood urate that forms crystals in joint tissue, causing inflammation and pain the hallmark of this disease…

]]> http://www.healthblognews.com/scientists-out-a-gene-for-gout-2/feed/ 0 http://www.healthblognews.com/ardea-biosciences-initiates-phase-2b-clinical-trial-of-rdea594-lead-product-candidate-for-the-treatment-of-gout-2/ http://www.healthblognews.com/ardea-biosciences-initiates-phase-2b-clinical-trial-of-rdea594-lead-product-candidate-for-the-treatment-of-gout-2/#comments Sun, 10 Jan 2010 15:53:43 +0000 Healthblognews.com http://www.healthblognews.com/ardea-biosciences-initiates-phase-2b-clinical-trial-of-rdea594-lead-product-candidate-for-the-treatment-of-gout-2/ Ardea Biosciences, Inc. (Nasdaq:RDEA) today announced that it has initiated a Phase 2b clinical trial of RDEA594, its lead product candidate in development for the management of hyperuricemia and gout. The Company also announced the selection of RDEA684, a next-generation URAT1 inhibitor, as a development candidate for the same indication…

]]> http://www.healthblognews.com/ardea-biosciences-initiates-phase-2b-clinical-trial-of-rdea594-lead-product-candidate-for-the-treatment-of-gout-2/feed/ 0